#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-neutrophil cytoplasmic antibody positive vasculitis Idiopathic intracranial hypertension Warm autoimmune haemolytic anaemia Nasopharyngeal cancer Erythema multiforme Thrombocytopenia Biliary neoplasm Acute myeloid leukaemia Duchenne muscular dystrophy gene carrier Anal cancer Keratosis follicular Atopic keratoconjunctivitis Hyperadrenocorticism Chronic kidney disease Multifocal motor neuropathy More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Diagnostics Alagille syndrome Angelman’s syndrome – Diagnostics Paroxysmal nocturnal haemoglobinuria – Trials in Disease Stevens-Johnson syndrome – Trials in Disease Myelodysplastic syndrome – Treatment Progressive supranuclear palsy – Trials in Disease Mantle cell lymphoma stage II – Treatment Familial haemophagocytic lymphohistiocytosis – Trials in Disease Haemophilia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elafibranor Xxb750 M2Rlab VERT-002 Clopidogrel Zinc Acexamate Specific Nucleic Acid Sna-Ebv Amoxicillin Fasudil Hydrochloride Progesterone Oxazepam ANGIOTENSIN II Canagliflozin Mitotane Amy109 Niraparib Tosilate Monohydrate Vb10.16 Romidepsin Opevesostat Tosilate OLVEREMBATINIB More therapies…

    Learn about Your Condition

    Corneal graft failure Primary biliary cholangitis Rectal cancer Transitional cell carcinoma Renal cell carcinoma stage IV Mantle cell lymphoma recurrent Fibrosarcoma metastatic Alport's syndrome Fatty acid oxidation disorder Persistent depressive disorder Renal injury Ear discomfort Macular degeneration Acute myocardial infarction Ureteric cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Oxygen and Nitrous Oxide Use in Critically Ill Adults on Ventilators

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Nitrous Oxide
    • Oxygen
    Italy

  • Study on EGFR-Mutated Lung Cancer: Evaluating Dacomitinib, Afatinib, and Osimertinib for Patients Not Suitable for Curative Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Dacomitinib
    • Afatinib
    • Osimertinib
    Sweden

  • Study on the Effects of Mesenchymal Stem Cells and Human Albumin Solution on Organ Failure in Patients with Severe Septic Shock

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Albumin
    • Csm-Gw
    • Human Albumin Solution
    France

  • Study of Ebastine and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients with Advanced Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Ebastine
    • Cabazitaxel
    • Docetaxel
    Denmark

  • Study on Methadone and Sufentanil for Pain Management After Orthopedic Surgery in Patients Without Locoregional Anesthesia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Methadone Hydrochloride
    • Sufentanil
    Belgium

  • Study of esomeprazole effects on endoscopic sleeve gastroplasty structural integrity in obese patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Esomeprazole
    Italy
Previous Page
1 … 297 298 299 300 301 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!